Artigos Científicos Palavras-chaveActa Médica PortuguesaAmerican Journal of HematologyAngiologia e Cirurgia Vascularartigo cientificoartigo revisãoBloodBlood AdvancesBlood Coagulation & FibrinolysisBritish Journal of HaematologyClinical and Applied Thrombosis / HemostasisClinical Case ReportsEuropean Heart Journal - Cardiovascular PharmacotherapyEuropean Journal of Case Reports in Internal MedicineHaemophiliaJournal of American College of CardiologyJournal of American Heart AssociationJournal of Clinical MedicineJournal of Thrombosis and HaemostasisLa Press Médicalmeta-analiseNew England Journal of Medicinenoticiasprimeira reunião APTHResearch and Practice in Thrombosis and HaemostasisRevista Clínica EspañolaRevista Portuguesa de CardiologiaSeminars in Thrombosis and HemostasisSience AdvancesThe Lancet HaematologyThrombosis and HaematologyThrombosis JournalThrombosis ResearchAAVAbdominal or pelvic cancer surgeryABO blood-groupAbsolute immature platelet countAcidente vascular cerebralacquired blood coagulation disordersAcquired coagulation disorderacquired hemophiliaAcquired von Willebrand diseaseAcute myeloid leukemiaAcute phase responseacute venous thromboembolismADAMTS13AetiologyAftercareagingagingphosphoproteomeplateletstandem mass tagthrombosisAlgorithmalgorithmsAllele-selective silencingAnabolic-androgenic steroidsanaemiaAnd North AfricaandexanetAnemiaAnemia diagnósticoAnemia FerropénicaAnemia TratamentoAnimal modelanimal testing reductionanimal use alternativesankle sprainAnti-coagulantAnti-inflammationantibodiesantibodies complement heparin-induced thrombocytopenia (HIT) platelet factor 4 (PF4) serotonin release assay (SRA)antibody inhibitorAnticoagulantAnticoagulant proteinanticoagulant reversalAnticoagulantes Orais DiretosanticoagulantsAnticoagulationAnticoagulation qualityAnticoagulation therapyAntiphospholipid antibodiesAntiphospholipid syndromeAntiplateletAntiplatelet medicationAntithrombinantithrombin concentratesantithrombin deficiencyAntithrombin III deficiencyAntithrombinsAntithromboticAntithrombotic prophylaxisAortic valve stenosisAPACApixabanApixabanoaPL carriersaPL carriers Antithrombotic prophylaxisApoptosisAromatase inhibitorsArterial diseaseArtificial intelligenceAscitesASGR2AspirinAsundexianAtherosclerosisAtrial fibrillationavatrombopagBethesda assaybile acidsbiomarkerBiomarkersBiomarkers/bloodBleedingBleeding disorderbleeding disordersbleeding managementblood clotBlood coagulationBlood Coagulation DisordersBlood coagulation factorsBlood Coagulation Testsblood platelet disorderblood platelet disordersblood plateletsBlood TransfusionBreast cancerBridgingBudd-Chiari syndromeCA-125Caesarean deliveryCancerCancer associated thrombosisCancer-associated venous thromboembolismCaprini VTE risk assessment scalecardiopulmonary bypassCardiovascular complicationsCardiovascular diseasecardiovascular diseasesCentral retinal vein occlusionCentral venous access device-related thrombosiscerebral thrombosiscerebral venous sinus thrombosisCerebral venous thrombosisCerebrovascular disordersChemotherapyChildChildrenChinaChronic thromboembolic pulmonary hypertensionChronic venous diseasecirculating endothelial cellsCirrhosisClassification criteriaCLEC-2 (C-type lectin-like receptor-2)CLEC4MClinical manifestationclinical practice guidelineClonal hematopoiesisClusterClustersCoagulationCoagulation factorscoagulopathyCohort studiesCollagenCommunicationCompeting riskcomputed tomographyComputed tomography pulmonary angiographyCongenital fibrinogen disordersConsensusconstrictionContraceptive agentsContraceptive devicesCoronary artery diseaseCoronavirus InfectionsCostsCOVID-19COVID-19 vaccinesCOVID-19* / epidemiologycritical illnesscryoelectron microscopyCytokinesD-dimerDabigatranoDanaparoiddecompression sicknessDeep vein thrombosisDeep venous thrombosisDeficiencydelphi techniqueDermatomyositisDescriptive studiesDesmopressinDiagnosecodesDiagnosisdiagnostic testsDICDirect oral anticoagulantsDisseminated intravascular coagulationDOACDOACsDOAFF studyDoença Renal Crónicadrug delivery systemsDysfibrinogenemiaDyspneaDyspnoeaEchocardiographyECMECMOEconomic burdenEdoxabanoEfanesoctocog Alfaelderly patientsEmbolic stroke of undetermined sourceembolism and thrombosisEmicizumabendothelial cellEndothelial cellsEndotheliumEndovascular treatmentenhanced VWF clearanceEpidemiologyestrogenestrogensEthinyl estradiolevidence-based medicineevidence-based practiceExerciseExercise testextracellular trapsextracorporeal membrane oxygenationF9factor concentratesFactor II inhibitorfactor IXfactor IX deficiencyfactor IX-PaduaFactor VIIfactor VIIIfactor VIII deficiencyFactor XaFactor Xa inhibitorsFactor XIfactor XI inhibitorsFeasibility studiesFerumoxytolFibrilhação auricularfibrinFibrin clotfibrin clot lysis timeFibrin clot propertiesFibrinogenFibrinóliseFibrinolysisfibrosisFondaparinuxFontanForecastsfostamatinibfreeze-driedFVIII inhibitorsFXI inhibitiongastrointestinal bleedingGendergender incongruenceGender perspectiveGender-affirming hormone therapygene editingGene expressionGene therapygenetic analysisgenetic carrier screeningGenetic correlationgenetic disordersGenetic overlapGenotypingGPIbαGRADEgrade approachguidelineguidelinesGWASHaematologyHaemophiliaHaemophilia AhaemostasisHCCHealth care economicsHealthcare professional perspectiveHealthcare professional perspectiveLung cancerPatient informationCommunicationheart assist devicesHeatstrokeHeavy menstrual bleedingHeavy menstrual bleeding (HMB)hemarthrosisHematologicHematologyHematology & PlateletshematuriaHemodialysishemophiliahemophilia Ahemophilia BHemoptysisHemorragiaHemorragia Pós-PartoHemorrhageHemostasishemostatic agentHeparinheparin low molecular weightheparin resistanceheparin-induced thrombocytopeniaHeparinshepatitisHepatocytehistory of medicineHodgkin lymphomaHospitalizationHospitalsHSCs (hematopoietic stem cells)Hughes-Stovin syndromehuman* / epidemiologyhuman* / prevention & controlhydrogen-deuterium exchange mass spectrometryhyperstabilizationhypoalbuminemiaHypofibrinogenemiaIdarucizumabImmune thrombocytopeniaImmune tolerance inductionimmunityimmunotherapyimmunothrombosisimplementation scienceIMPROVEIn-hospital mortalityInfecções por CoronavírusinferiorInflamationinflammationInfluenzainheritedInhibitorInhibitorsInibidores de Prolil-HidrolaseInibitors ThrombininnateINRInsuficiência cardíacaIntermediate-high riskInternational normalized ratioIntracerebral hemorrhageIntracranial hemorrhagesintravenous immunoglobulinsIron Deficienciesiron deficiencyIron-DeficiencyischemiaIschemic heart diseaseIschemic strokeIsolated cortical vein thrombosisISTHJAK2 proteinJanus kinase 2Jointknee arthroplastylaboratory haematologyLarge language model (LLM)Latent growth mixture modelLDLRLeft atrial diseaseLeft ventricular diseaseLeft ventricular thrombusLeukemiaLeukemicLiverliver cirrhosisliver diseaseslocal disorderLoVICLoVIC studyLow molecular weight heparinLow VWFLow-molecular-weight heparinsLow-molecular-weight heparins Cancer Abdominal or pelvic cancer surgery Venous thromboembolism Hemorrhage Network meta-analysisLower gastrointestinal bleedingluminescent assayLung cancerLupus anticoagulantlupus coagulation inhibitorLupus-associated hypoprothrombinemiaLymphomalyophilizedMachine learningMagnetic resonanceMagnetic resonance imagingMajor bleedsManagementmanagement algorithmMarketmassiveMaternal healthMechanical heart valvemechanicsMediation analysisMedical patientsmegakaryocytesMendelian randomizationMeta-analysisMethylglyoxal modificationMicroparticlesMicroplasticsMiddle EastMIS-CMissense mutationmolecular diagnosisMortalityMortality trendsMousemRNAmtDNA copy numberMultidetector computed tomographymultiple myelomamultirefractory immune thrombocytopeniaMurine modelsMutationmyeloproliferative disordermyeloproliferative disordersNegative feedbackneoplasmsNETsNetwork meta-analysisneurobehavioral abnormalitiesneutralisingneutrophilsNijmegen assayNLPNOACsNomogramNursesNXT007ObesityObservational studyOctaplexOlder patientsOral anticoagulantOral anticoagulationOrgan dysfunctionOutcomesOutcomes & QualityOxidative stressPAI-1partial thromboplastin timePatent foramen ovalepathologicPatient experiencePatient informationpatient preferencePDPN (podoplanin)PDPN KO (PDPN knockout line)PDPN WT (PDPN-expressing stromal cell line)PediatricPediatric hematologyPediatricsPepsinPercutaneous coronary interventionPerioperativePerioperative CarePeripheral artery diseasePeriproceduralpermeabilityPerturbações da Coagulação SanguíneaPF4 antibodiespharmacodynamicphosphoproteomePhysical activityplasminogen activatorsplasminogen deficiencyplateletplatelet activationPlatelet activityPlatelet aggregationplatelet aggregation inhibitorsPlatelet countPlatelet dysfunctionplatelet factor 4Platelet FcγRIIAPlatelet functionplatelet function testsplatelet granulesplatelet storage pool deficiencyplatelet transfusionPlateletsPleiotropic lociPoint-of-care-testingpolycystic ovary syndromepolycythemia veraPolycythemia vera Red cell mass Radioisotope labeling Scintigraphy ThrombosisPolymyositispopulation-basedportal veinportal vein thrombosisPost-phlebitic syndromePost-thrombotic syndromePost-translational modificationPostoperative bleedingPostpartumPostpartum Hemorrhagepostpartum periodPostthrombotic syndromePPARαPractice patternsPredictionPrediction modelpregnancyPregnancy complicationsprimary prophylaxisProgestinPrognosispromotorProphylaxisPROS1Prosthetic valve dysfunctionprotein C deficiencyProtein carbonylationProtein kinase Cprotein S deficiencyProtein structureProthrombin complexprothrombin complex concentratesprotocolProtocolos ClínicosPTPPulmonary arterial hypertensionPulmonary artery aneurysmsPulmonary embolismPulmonary hypertensionPulmonary vasculitisPUPQualitativeRadioisotope labelingRadiologyrecombinant fusion proteinsRecombinant human thrombomodulinRecurenceRecurrenceRed cell massReduced dose Apixabanrefinement and replacementReperfusionResourcesRetinal vascular diseaseRIETErisk assessmentRivaroxabanRivaroxabanosalivaSARS-CoV-2Scintigraphyscuba divingsecondary prevention of venous thromboembolismsepsisSepsis-induced coagulopathySerpin E2serum albuminSevere Hemophilia ASevere maternal morbiditySexSex disparitiesShear stressSingle photon emission computed tomographysiRNAsplanchnic circulationSplanchnic venous thrombosisSplenectomySpontaneous echo contrastSTAB2StewardshipStroke in the youngSubsegmental pulmonary embolismSubtherapeuticSuperficial thrombophlebitisSuperficial vein thrombosisSurgical aortic valve replacementSurveyT-TASTamoxifentandem mass tagTestes de Coagulação SanguíneatestingTestosteroneTherapeutic advancesTHPH5ThrombelastographyThrombinThrombin generationThrombocytopeniathromboelastographyThromboelastometrythromboembolismThromboinflammationThrombolytic therapythrombophiliaThrombopoietin receptor agonistsThromboprophylaxisThrombosisThrombosis modelsThrombosis modelsECM Shear stress EndotheliumThrombotic riskthrombotic thrombocytopenic purpuraThrombusthrombus resolutiontissue engineeringTissue factorTrajectoryTransfusão de Sanguetransfusiontranslational science—biomedicalTranstornos da Coagulação SanguíneatreatmentTriNetX databaseTromboelastografiaTromboelastometriaTromboseTrombose Venosa ProfundaTumourTXA (tranexamic acid)Type 1 VWDtype 1C VWDUnfractionated heparinUpper extremity deep vein thrombosisUpper gastrointestinal bleedingvaccine-induced immune thrombocytopeniavaccine-induced thrombocytopenia and thrombosisValvular heart diseasevariceal and nonvaricealVascular MedicineVascular risk factorsVE-cadherinvemous thromboembolismvena cavavena cava agenesisVenous diseaseVenous thrombeombolismVenous thromboembolismVenous thromboembolism (VTE)venous thrombosisVenous ulcervia extrinsicVitamin K antagonistsVKAvon Willebrand diseaseVon Willebrand factorVTEVWDVWFVWF multimer analysisVWF-R1205H (Vicenza)WarfarinWeibel-Palade bodiesWFHWillebrandWiN studywomen’s healthWY-14643α- δ- (dense) granulesα-2 antiplasmin Load MoreEnd of Content. Thrombosis, Translational Medicine, and Biomarker Research: Moving the Needle Ler Mais Identification of phenotypes and predictors for dyspnea, echocardiographic probability of pulmonary hypertension, and confirmed CTEPH in patients with acute pulmonary embolism: Analysis of two large patient cohorts Ler Mais Long-term recurrence, bleeding, and mortality after first-time subsegmental pulmonary embolism compared to more proximal pulmonary embolism: Findings from the TROLL registry Ler Mais Treating the mind and body: implementation of a psychosocial wellbeing assessment in the deep vein thrombosis clinic Ler Mais Clinical phenotypes and risk of early hemodynamic deterioration in intermediate-high-risk patients with acute pulmonary embolism Ler Mais Neutrophil extracellular traps-related markers in chronic limb threatening ischemia – a relation with progression and prognosis Ler Mais The effect of exercise-based rehabilitation on objective physical activity levels in patients with persistent dyspnoea following pulmonary embolism Ler Mais Control of warfarin treatment in patients with antiphospholipid syndrome and falsely high INR at point-of-care-testing Ler Mais Sex-based differences in access to reperfusion therapies for pulmonary embolism in Spain during the 2016–2022 period Ler Mais Performance of new 2023 ACR/EULAR antiphospholipid syndrome classification criteria in young patients admitted for pulmonary embolism Ler Mais All-cause mortality after major gastrointestinal bleeding among patients receiving direct oral anticoagulants: a systematic review and meta-analysis Ler Mais Selected cell receptor genotypes differentially modulate the ABO blood group influence on Factor VIII levels in severe aortic stenosis Ler Mais An audit of postpartum thromboprophylaxis practices and outcomes following caesarean delivery Ler Mais How we treat severe inherited antithrombin deficiency: lessons from cases homozygous for the Budapest 3 variant Ler Mais Intravenous immunoglobulin prevents thrombosis in an endothelialized disease model of heparin-induced thrombocytopenia Ler Mais Cost of immune tolerance induction according to its outcome in people with hemophilia A and inhibitors: results from the Co$tIT study Ler Mais EKITE phase 2: A valuable readily available resource for patient education on thrombosis and warfarin anticoagulation therapy Ler Mais Antiplatelet-anticoagulant, APAC, a mimic of endogenous heparin, is an antithrombotic with von Willebrand factor-mediated characteristics Ler Mais Splanchnic vein thrombosis (2003−2022): a Swiss nationwide epidemiological study Ler Mais Phenotype, genotype, and laboratory assessment of congenital fibrinogen disorders: Data from the Rare Bleeding disorders in the Netherlands study Ler Mais Load More
Identification of phenotypes and predictors for dyspnea, echocardiographic probability of pulmonary hypertension, and confirmed CTEPH in patients with acute pulmonary embolism: Analysis of two large patient cohorts Ler Mais
Long-term recurrence, bleeding, and mortality after first-time subsegmental pulmonary embolism compared to more proximal pulmonary embolism: Findings from the TROLL registry Ler Mais
Treating the mind and body: implementation of a psychosocial wellbeing assessment in the deep vein thrombosis clinic Ler Mais
Clinical phenotypes and risk of early hemodynamic deterioration in intermediate-high-risk patients with acute pulmonary embolism Ler Mais
Neutrophil extracellular traps-related markers in chronic limb threatening ischemia – a relation with progression and prognosis Ler Mais
The effect of exercise-based rehabilitation on objective physical activity levels in patients with persistent dyspnoea following pulmonary embolism Ler Mais
Control of warfarin treatment in patients with antiphospholipid syndrome and falsely high INR at point-of-care-testing Ler Mais
Sex-based differences in access to reperfusion therapies for pulmonary embolism in Spain during the 2016–2022 period Ler Mais
Performance of new 2023 ACR/EULAR antiphospholipid syndrome classification criteria in young patients admitted for pulmonary embolism Ler Mais
All-cause mortality after major gastrointestinal bleeding among patients receiving direct oral anticoagulants: a systematic review and meta-analysis Ler Mais
Selected cell receptor genotypes differentially modulate the ABO blood group influence on Factor VIII levels in severe aortic stenosis Ler Mais
An audit of postpartum thromboprophylaxis practices and outcomes following caesarean delivery Ler Mais
How we treat severe inherited antithrombin deficiency: lessons from cases homozygous for the Budapest 3 variant Ler Mais
Intravenous immunoglobulin prevents thrombosis in an endothelialized disease model of heparin-induced thrombocytopenia Ler Mais
Cost of immune tolerance induction according to its outcome in people with hemophilia A and inhibitors: results from the Co$tIT study Ler Mais
EKITE phase 2: A valuable readily available resource for patient education on thrombosis and warfarin anticoagulation therapy Ler Mais
Antiplatelet-anticoagulant, APAC, a mimic of endogenous heparin, is an antithrombotic with von Willebrand factor-mediated characteristics Ler Mais
Phenotype, genotype, and laboratory assessment of congenital fibrinogen disorders: Data from the Rare Bleeding disorders in the Netherlands study Ler Mais
